Domain Associates
Venture capitalPrinceton · Seed–Series C
Investment thesis
The firm specializes exclusively in biotech investments, having pioneered dedicated venture capital funding for the biotechnology sector since its inception. With a history spanning nearly four decades, DomainVC has established deep expertise in identifying and nurturing biotech companies through multiple investment cycles.
Source: firm website, verified Jul 21, 2026.
What they invest in
from 3 of 3 portfolio companiesBiotech ×3Medical Devices ×2AI & Machine Learning ×1Deep Tech ×1Digital Health ×1Enterprise Software ×1Healthtech ×1
HQs:United States×1
Investments · 3 tracked
founders shown can be your intro pathAspen Neuroscience develops iPSC-derived autologous cell therapies for neurological diseases, with a lead product (ANPD001) in Phase 1/2a clinical trials for Parkinson's disease. The company is a clinical-stage biotechnology firm focused on personalized neuron replacement therapies.
BiotechDeep TechDigital HealthMedical Devices<UNKNOWN>, US
Andrés Bratt-Leal(Co-Founder and Senior Vice President, Research & Development)Damien McDevitt(President and Chief Executive Officer)
ChromaCode develops a High-Definition PCR (HDPCR) multiplexing platform that enables genomic solutions for oncology and precision medicine, offering faster results and cost-effective workflows through automated interpretation and cloud-based software.
AI & Machine LearningBiotechMedical Devices
Thermo Fisher Scientific operates a commercial platform for registered customers, distributors, and authorized representatives to purchase products and services in the life sciences sector.
BiotechEnterprise SoftwareHealthtech
Frequently asked questions
- What stage does Domain Associates invest at?
- Domain Associates invests at the Seed, Series A, Series B, Series C stages.
- What sectors does Domain Associates focus on?
- Domain Associates focuses on Biotech.
- Where is Domain Associates located?
- Domain Associates is headquartered in Princeton, US.
Similar investors
a16z is a venture capital firm founded in 2009 by Marc Andreessen and Ben Horowitz that invests in seed through growth-stage technology companies across multiple sectors including AI, healthcare, consumer, crypto, enterprise, fintech, and gaming. The firm manages over $100 billion in assets and operates a distinctive platform model with a large team of operators supporting founders throughout their journey.
B Capital is a venture capital firm managing over $12 billion in assets with a stage-based fund approach. The firm invests across early to late-stage companies in technology, healthcare, and energy & resilience sectors, with 200+ portfolio companies and 9 global offices.
Bessemer Venture Partners is a venture capital firm with a 50-year history supporting entrepreneurs in building enduring companies globally. The firm draws on deep operational expertise and advisory relationships to support portfolio companies through their growth journey.
Breyer Capital is a venture capital firm that invests in high-impact entrepreneurs with a strategic focus on companies leveraging artificial intelligence and machine learning to transform technology sectors globally.
DCVC is a deep tech venture capital firm with over a dozen years of experience backing entrepreneurs using computational approaches to solve trillion-dollar problems across industries including AI, climate, materials science, robotics, space, and biology.